CRISPR THERAPEUTICS AG Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
CRISPR THERAPEUTICS AG (CRSP) had Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance of 17.69 million shares as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance · last filed 2026-08-03
- 2026-06-30: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 17.69M shares.
- 2026-03-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 17.69M shares.
- 2025-12-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 19.54M shares.
- 2025-09-30: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 19.54M shares.
| Period end | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 17.69M shares 10-Q · filed 2026-08-03 |
| 2026-03-31 | 17.69M shares 10-Q · filed 2026-05-04 |
| 2025-12-31 | 19.54M shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 19.54M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 19.54M shares 10-Q · filed 2025-08-04 |
| 2025-03-31 | 19.54M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 20.93M shares 10-K · filed 2025-02-11 |
| 2024-09-30 | 20.93M shares 10-Q · filed 2024-11-05 |
| 2024-06-30 | 20.93M shares 10-Q · filed 2024-08-05 |
| 2024-03-31 | 19.93M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 20.99M shares 10-K · filed 2024-02-21 |
| 2023-09-30 | 20.99M shares 10-Q · filed 2023-11-06 |
| 2023-06-30 | 20.99M shares 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |